WINT · OTC
Companies at this level ended the following year delisted, bankrupt, restated or silent 13.1% of the time, against 4.0% for companies with a clean record.
Hover or tap a dot to see the filings behind that score.
As reported in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, our existing resources are limited. In response to our limited liquidity, the Company is seeking sources of capital through potential strategic transactions. The Company management has devoted significant resources toward finalizing its financial statements and disclosures, however, the Company was required to devote a significant amount of time and other Company resources to other matters such as financing opportunities, which normally would be devoted to the preparation of the Annual Report on Form 10-K (the “Form 10-K”) and related matters. There can be no assurance that a strategic transaction will be consummated. As a result of these factors, the Company’s limited resources have caused a delay in the Company’s ability to complete and file its Form 10-K for the fiscal year ended December 31, 2025 by the required deadline without unreasonable effort and expense. The Company expects to be in a position to file the Form 10-K on or before April 15, 2026, the prescribed due date under the fifteen calendar day extension period provided under Rule 12b-25 under the Securities Exchange Act of 1934
NT 10-K, filed 2026-04-01 · liquidity
As reported in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, our existing resources are limited. In response to our limited liquidity, the Company is seeking sources of capital through potential strategic transactions. The Company management has devoted significant resources toward finalizing its financial statements and disclosures, however, the Company was required to devote a significant amount of time and other Company resources to other matters such as financing opportunities, which normally would be devoted to the preparation of the Annual Report on Form 10-K (the “Form 10-K”) and related matters. There can be no assurance that a strategic transaction will be consummated. As a result of these factors, the Company’s limited resources have caused a delay in the Company’s ability to complete and file its Form 10-K for the fiscal year ended December 31, 2025 by the required deadline without unreasonable effort and expense. The Company expects to be in a position to file the Form 10-K on or before April 15, 2026, the prescribed due date under the fifteen calendar day extension period provided under Rule 12b-25 under the Securities Exchange Act of 1934
Windtree Therapeutics, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 (the “Form 10-Q”) within the prescribed time period without unreasonable effort and expense because additional time is required to finalize the Company’s financial statements and related disclosures required to be included in the Form 10-Q. The Company expects to file the Form 10-Q within five calendar days following the prescribed due date
Windtree Therapeutics, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the “Form 10-Q”) within the prescribed time period without unreasonable effort and expense because additional time is required to finalize the Company’s financial statements and related disclosures required to be included in the Form 10-Q. The Company expects to file the Form 10-Q within five calendar days following the prescribed due date
As reported in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, our existing resources are limited. In response to our limited liquidity, the Company is seeking sources of capital through potential strategic transactions. The Company management and accounting personnel have devoted significant resources toward finalizing its financial statements and disclosures, however, the Company was required to devote a significant amount of time and other Company resources to other matters such as financing opportunities, which normally would be devoted to the preparation of the Annual Report on Form 10-K (the “Form 10-K”) and related matters. There can be no assurance that a strategic transaction will be consummated. As a result of these factors, the Company’s limited resources have caused a delay in the Company’s ability to complete and file its Form 10-K for the fiscal year ended December 31, 2024 by the required deadline without unreasonable effort and expense. The Company expects to be in a position to file the Form 10-K on or before April 15, 2025, the prescribed due date under the fifteen calendar day extension period provided under Rule 12b-25 under the Securities Exchange Act of 1934
As reported in the Company’s most recent Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, the Company did not have sufficient cash and cash equivalents as of the date thereon to support its operations for at least 12 months. In response to this liquidity issue, the Company has streamlined its operations and curtailed expenses while, at the same time, is seeking sources of capital through potential strategic transactions. The Company’s management and accounting personnel have devoted significant resources toward finalizing its financial statements and disclosures, however, the Company was required to devote a significant amount of time and other Company resources to other matters such as financing opportunities, which normally would be devoted to the preparation of the Quarterly Report and related matters. As result of these factors, the Company’s limited resources have caused a delay in the Company’s ability to complete and file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Form 10-Q”) by the required deadline without unreasonable effort and expense. The Company expects to be in a position to file the Form 10-Q on or before November 19, 2024, the prescribed due date under the five calendar day extension period provided under Rule 12b-25 under the Securities Exchange Act of 1934
As reported in the Company’s most recent Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, the Company did not have sufficient cash and cash equivalents as of the date thereon to support its operations for at least 12 months. In response to this liquidity issue, the Company has streamlined its operations and curtailed expenses while, at the same time, is seeking sources of capital through potential strategic transactions. The Company’s management and accounting personnel have devoted significant resources toward finalizing its financial statements and disclosures, however, the Company was required to devote significant time towards the completion of its most recent financing as disclosed on the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 22, 2024, and therefore was delayed in finalizing its financial statements for the quarter ended June 30, 2024. As result of these factors, the Company’s limited resources have caused a delay in the Company’s ability to complete and file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Form 10-Q”) by the required deadline without unreasonable effort and expense. The Company expects to be in a position to file the Form 10-Q on or before August 19, 2024, the prescribed due date under the five calendar day extension period provided under Rule 12b-25 under the Securities Exchange Act of 1934
As reported in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, our existing resources were not sufficient to support our development activities and fund our business operations beyond the first quarter of 2024. In response to this liquidity issue, the Company has streamlined its operations and curtailed expenses while, at the same time, is seeking sources of capital through potential strategic transactions. The Company to date has not been able to raise additional debt or equity capital and has continued to explore its strategic options. There can be no assurance that a strategic transaction will be consummated. As result of these factors, the Company’s limited resources have caused a delay in the Company’s ability to complete and file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”) by the required deadline without unreasonable effort and expense. The Company expects to be in a position to file the Form 10-K on or before April 16, 2024, the prescribed due date under the fifteen calendar day extension period provided under Rule 12b-25 under the Securities Exchange Act of 1934
2022-05-11auditor changed or resigned SEC →
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice